These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36847559)

  • 61. Susceptibility of Cutibacterium acnes to topical minocycline foam.
    Sutcliffe J; McLaughlin R; Webster G; Read AF; Drlica K; Elliott R; Stuart I
    Anaerobe; 2020 Apr; 62():102169. PubMed ID: 32058277
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics.
    Park SY; Kim HS; Lee SH; Kim S
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
    Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
    Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.
    Lomakin IB; Devarkar SC; Grada A; Bunick CG
    J Invest Dermatol; 2024 Nov; 144(11):2553-2561.e3. PubMed ID: 39122144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Culturable bacteria in the entire acne lesion and short-chain fatty acid metabolites of Cutibacterium acnes and Staphylococcus epidermidis isolates.
    Huang TY; Jiang YE; Scott DA
    Biochem Biophys Res Commun; 2022 Sep; 622():45-49. PubMed ID: 35843093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics.
    Iinuma K; Noguchi N; Nakaminami H; Sasatsu M; Nishijima S; Tsuboi I
    Clin Cosmet Investig Dermatol; 2011; 4():161-5. PubMed ID: 22087070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic Efficacy of Sesquiterpene Farnesol in Treatment of
    Wu GX; Wang YW; Wu CS; Lin YH; Hung CH; Huang HH; Kuo SM
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577195
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unravelling the eco-specificity and pathophysiological properties of Cutibacterium species in the light of recent taxonomic changes.
    Dekio I; Asahina A; Shah HN
    Anaerobe; 2021 Oct; 71():102411. PubMed ID: 34265438
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative Proteomic Analysis of Membrane Vesicles from Clinical
    Jiang M; Fan X; Jiang Z; Chen H; Liu Y; Yu T; Huang Q; Ma Y
    Clin Cosmet Investig Dermatol; 2022; 15():703-712. PubMed ID: 35463830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
    Swallow MA; Fan R; Cohen JM; Bunick CG
    Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW; Gloor M; Dietz P; Höffler U
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emergence of Cutibacterium avidum with
    Koizumi J; Nakase K; Nakaminami H
    Microbiol Resour Announc; 2023 Jul; 12(7):e0017823. PubMed ID: 37272804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of
    Espinoza-Monje M; Campos J; Alvarez Villamil E; Jerez A; Dentice Maidana S; Elean M; Salva S; Kitazawa H; Villena J; García-Cancino A
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361921
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic Effect of a Newly Isolated Lytic Bacteriophage against Multi-Drug-Resistant
    Lam HYP; Lai MJ; Chen TY; Wu WJ; Peng SY; Chang KC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209998
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris.
    Woodburn KW; Jaynes J; Clemens LE
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31940992
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.